Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2021 | $196,021 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2010 | $195,448 | | tax credit/rebate |
IMPAX LABORATORIES, INC. | Amneal Pharmaceuticals | California | state | 2011 | $195,440 | | training reimbursement |
JOHNSON & JOHNSON (UNDER MEMPHIS TRADE) | Johnson & Johnson | Tennessee | local | 2013 | $195,430 | | property tax abatement |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2005 | $195,386 | | tax credit/rebate |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2012 | $195,000 | | grant |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $194,803 | | tax credit/rebate |
Regeneron Columbia Project | Regeneron Pharmaceuticals | New York | local | 2020 | $192,947 | | tax credit/rebate |
Regeneron 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2020 | $192,947 | | tax credit/rebate |
Novartis Animal Health US Inc. | Novartis | Iowa | state | 2004 | $191,891 | | training reimbursement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2009 | $191,863 | | property tax abatement |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $191,699 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2009 | $191,686 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2012 | $191,566 | | enterprise zone |
GILEAD SCIENCES INC | Gilead Sciences | California | state | 2015 | $191,250 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2013 | $191,000 | | enterprise zone |
GILEAD SCIENCES, INC. | Gilead Sciences | California | state | 2011 | $190,995 | | training reimbursement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $190,111 | | property tax abatement |
Hospira, Inc. | Pfizer | Kansas | state | 2007 | $190,000 | | training reimbursement |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2019 | $189,845 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2016 | $189,472 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | Pfizer | North Carolina | state | 2015 | $187,566 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $185,655 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $184,567 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2017 | $184,344 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2016 | $184,324 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2017 | $183,559 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2009 | $182,015 | | property tax abatement |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2020 | $181,829 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $181,604 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $181,443 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $181,239 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2017 | $181,044 | | tax credit/rebate |
Purdue Pharma LP | Purdue Pharma | New York | local | 2004 | $180,174 | | tax credit/rebate; property tax abatement |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $180,014 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2018 | $179,068 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2014 | $178,257 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2005 | $178,127 | | tax credit/rebate |
Johnson & Johnson Consumer Inc. | Johnson & Johnson | Florida | state | 2018 | $175,000 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2016 | $174,626 | | tax credit/rebate |
Regeneron Renovation | Regeneron Pharmaceuticals | New York | local | 2016 | $173,504 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2019 | $172,893 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2018 | $171,783 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2017 | $171,780 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2019 | $171,670 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas, Inc. | GlaxoSmithKline | North Carolina | state | 2015 | $171,518 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $170,504 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2008 | $169,868 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2022 | $169,333 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $169,007 | | tax credit/rebate |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,537 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $168,442 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,371 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $167,753 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2021 | $167,626 | | tax credit/rebate |
Johnson & Johnson | Johnson & Johnson | New York | local | 2003 | $167,430 | | tax credit/rebate; property tax abatement |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Albany Molecular | Curia Inc. | New York | local | 2013 | $166,931 | | tax credit/rebate; property tax abatement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2006 | $165,000 | | grant/loan hybrid program |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2012 | $162,846 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $162,504 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2016 | $162,288 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2019 | $162,248 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $161,293 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $161,044 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2012 | $160,814 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2018 | $160,733 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2020 | $160,465 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2015 | $160,237 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2017 | $160,094 | | tax credit/rebate |
Johnson & Johnson Merck Consumer Pharmaceuticals | Johnson & Johnson | Pennsylvania | state | | $160,000 | | training reimbursement |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2013 | $160,000 | | tax credit/rebate |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2011 | $159,381 | | tax credit/rebate |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2010 | $158,808 | | training reimbursement |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $158,503 | | tax credit/rebate |
CASCADIAN THERAPEUTICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $157,351 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $156,516 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2021 | $156,185 | | tax credit/rebate |
United Therapeutics | United Therapeutics | North Carolina | state | 2012 | $155,750 | | grant |
Wyeth | Pfizer | Pennsylvania | state | 2009 | $154,958 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $154,920 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2009 | $154,593 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2011 | $153,972 | | enterprise zone |
Pfizer (project 2) | Pfizer | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2021 | $151,608 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2017 | $150,152 | | tax credit/rebate |
Clay-Park Labs Inc. | Perrigo | New York | state | 2006 | $150,000 | | enterprise zone |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | Pennsylvania | state | | $150,000 | | training reimbursement |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $150,000 | | tax credit/rebate |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2013 | $150,000 | | grant |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2012 | $150,000 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $150,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | | $150,000 | | grant |